Callahan Denise, Kovacs Christopher, Lynch Shawn, Rah Marjorie
Bausch & Lomb Incorporated, Rochester, New York, USA.
Clin Exp Optom. 2017 Jul;100(4):357-364. doi: 10.1111/cxo.12509. Epub 2017 Feb 14.
Because corneal infiltrative events (CIEs) may result from bacterial components on contact lenses, which can come from contaminated lens cases, we evaluated the biocidal efficacy of five multipurpose solutions against Gram-negative commonly isolated and CIE-associated organisms.
Of the multipurpose solutions tested, one contained polyhexamethylene biguanide (PHMB)/polyquaternium-1 (PQ-1; Bausch & Lomb Incorporated: Biotrue), one contained alexidine dihydrochloride (alexidine)/PQ-1 (AMO: RevitaLens OcuTec) and three contained PQ-1/myristamidopropyl dimethylamine (MAPD; Alcon: Opti-Free PureMoist, PQ-1/MAPD-1; Opti-Free RepleniSH, PQ-1/MAPD-2; Opti-Free Express, PQ-1/MAPD-3). Challenge organisms were CIE-associated Achromobacter xylosoxidans, Delftia acidovorans and Stenotrophomonas maltophilia at manufacturer-recommended durations (stand-alone), in lens cases without lenses (up to seven days) and in lens cases with etafilcon A lenses (up to 30 days).
In stand-alone testing against CIE-associated organisms, PHMB/PQ-1 and alexidine/PQ-1 were significantly superior versus MAPD-based multipurpose solutions against A. xylosoxidans (all p ≤ 0.01), D. acidovorans (all p ≤ 0.001) and S. maltophilia (all p ≤ 0.05). In lens cases, PHMB/PQ-1 and alexidine/PQ-1 achieved greater than 3-log reductions against all challenge organisms at all times evaluated. PQ-1/MAPD-1 achieved a greater than 3-log reduction against D. acidovorans at 24 hours; PQ-1/MAPD-1 and PQ-1/MAPD-3 achieved greater than 3-log reductions at seven days against all organisms. In lens cases with lenses, PHMB/PQ-1 and alexidine/PQ-1 achieved greater than 3-log reductions against all organisms at all times. PQ-1/MAPD-1 and PQ-1/MAPD-3 achieved greater than 3-log reductions at seven or more days against all organisms. PQ-1/MAPD-2 did not achieve a greater than 3-log reduction at any time; some regrowth was observed.
PHMB- and alexidine-based multipurpose solutions demonstrated significantly greater biocidal activity compared with PQ-1/MAPD-based agents against Gram-negative organisms commonly isolated and CIE-associated pathogens.
由于角膜浸润事件(CIEs)可能由隐形眼镜上的细菌成分引起,而这些细菌成分可能来自受污染的镜盒,我们评估了五种多功能护理液对革兰氏阴性常见分离菌及与CIE相关的微生物的杀菌效果。
在所测试的多功能护理液中,一种含有聚六亚甲基双胍(PHMB)/聚季铵盐-1(PQ-1;博士伦公司:倍明视),一种含有二盐酸阿利西定(阿利西定)/PQ-1(爱尔康公司:焕新视明),三种含有PQ-1/肉豆蔻酰胺丙基二甲胺(MAPD;爱尔康公司:傲滴恒润,PQ-1/MAPD-1;傲滴全护理液,PQ-1/MAPD-2;傲滴乐明,PQ-1/MAPD-3)。挑战微生物为与CIE相关的木糖氧化无色杆菌、食酸戴尔福特菌和嗜麦芽窄食单胞菌,在制造商推荐的时长下(单独使用)、在无镜片的镜盒中(长达7天)以及在装有依他氟康A镜片的镜盒中(长达30天)进行测试。
在针对与CIE相关微生物的单独测试中,PHMB/PQ-1和阿利西定/PQ-1在对抗木糖氧化无色杆菌(所有p≤0.01)、食酸戴尔福特菌(所有p≤0.001)和嗜麦芽窄食单胞菌(所有p≤0.05)方面显著优于基于MAPD的多功能护理液。在镜盒中,PHMB/PQ-1和阿利西定/PQ-1在所有评估时间对所有挑战微生物均实现了大于3个对数级的减少。PQ-1/MAPD-1在24小时时对食酸戴尔福特菌实现了大于3个对数级的减少;PQ-1/MAPD-1和PQ-1/MAPD-3在7天时对所有微生物均实现了大于3个对数级的减少。在装有镜片的镜盒中,PHMB/PQ-1和阿利西定/PQ-1在所有时间对所有微生物均实现了大于3个对数级的减少。PQ-1/MAPD-1和PQ-1/MAPD-3在7天或更长时间对所有微生物均实现了大于3个对数级的减少。PQ-1/MAPD-2在任何时候都未实现大于3个对数级的减少;观察到有一些再生长现象。
与基于PQ-1/MAPD的制剂相比,基于PHMB和阿利西定的多功能护理液对常见分离的革兰氏阴性菌及与CIE相关的病原体表现出显著更强的杀菌活性。